Ignite Creation Date:
2025-12-25 @ 4:35 AM
Ignite Modification Date:
2026-01-29 @ 9:12 AM
Study NCT ID:
NCT02057718
Status:
COMPLETED
Last Update Posted:
2023-10-23
First Post:
2014-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Sponsor:
Mirum Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-05
First Submit QC Date:
None
Study First Post Date:
2014-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-17
Results First Submit QC Date:
None
Results First Post Date:
2021-07-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-18
Last Update Post Date:
2023-10-23
Last Update Post Date Type:
ACTUAL